Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A.

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...

The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...

Eli Lilly and Co. CEO David Ricks—IBJ’s newsmaker ... The new funding will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion ...

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Royal Caribbean is facing a lawsuit from a dozen passengers who claim they were filmed naked in their cabins while on the ...

Eli Lilly, the Indianapolis-based drugmaker behind pharmaceuticals such as Mounjaro, acquired the 84,000-square-foot facility at 10300 128th Ave. from Nexus in April 2024 with plans to use the ...

With Eli Lilly's diabetes and obesity products Mounjaro ... What to do with all that cash? One answer: the Indianapolis-based pharma giant on Monday laid out a plan for a board-approved share ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

(Yicai) Jan. 3 -- US pharma giant Eli Lilly’s Tirzepatide injection for blood sugar control and weight loss is now available ...